BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Eurobiomed - ECPv6.10.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Eurobiomed
X-ORIGINAL-URL:https://www.eurobiomed.org
X-WR-CALDESC:Évènements pour Eurobiomed
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220314T090000
DTEND;TZID=Europe/Paris:20220316T170000
DTSTAMP:20260406T093434
CREATED:20220113T100009Z
LAST-MODIFIED:20240607T072517Z
UID:6984-1647248400-1647450000@www.eurobiomed.org
SUMMARY:Pierre Fabre - Virtual Biopharma Partnering 2022
DESCRIPTION:The Executive Management Team at Pierre Fabre is pleased to invite prospective partners to the second edition of our custom and exclusive on-line partnering event.\nWe would welcome applications to attend from innovative biopharmaceutical companies developing new therapies in the areas of oncology\, dermatology and rare diseases.\nPartnership proposals to create mutual value through the leverage of our commercial capabilities in the areas of urology\, rheumatology\, and gynaecology/women’s health would also be welcome. \nWhat Pierre Fabre is looking for? \nPierre Fabre – Virtual Biopharma Partnering 2022 is aimed at Executives\, Business Development professionals and Researchers from biotechnology and pharmaceutical companies. \nWe would be pleased to learn about opportunities for partnerships in the following areas: \n\nOncology: We are looking for innovative therapies for the treatment of tumours\, ideally already at the clinical development stage. With a world-wide presence* we also welcome proposals for commercial stage licensing opportunities.\nDermatology: We are interested in Rx products\, particularly in the areas of immuno-dermatology\, onco-dermatology and paediatric dermatology. Our main focus is on assets in clinical development\, and commercial stage opportunities that would fit well with our global footprint*.\nRare Diseases: We welcome proposals for licensing and/or collaboration opportunities for innovative treatments in clinical development for orphan indications for which there is a strong unmet medical need.\nUrology\, Rheumatology\, and Gynaecology: With a comprehensive commercial footprint in Europe we are actively seeking partnerships for marketed or near to market products in these therapeutic are\n\nOur objectives for this event are \n\nTo provide you with a showcase for your company and your projects for innovative therapeutics\nTo enable you to learn more about our group and our vision for the future\nTo give you an opportunity to connect with the key decision makers within Pierre Fabre\nTo foster and nurture long term partnership\n\nClosing Date for Applications to Participate 28 February 2022 \nINFORMATION AND REGISTRATION\n  \nFor additional information\, please contact: Pierre-Fabre.BDcontact@pierre-fabre.com
URL:https://www.eurobiomed.org/evenement/pierre-fabre-virtual-biopharma-partnering-2022/
CATEGORIES:Évènement partenaire
ATTACH;FMTTYPE=:
END:VEVENT
END:VCALENDAR